Blondel Hazel

Array ( [id] => 2490170 [patent_doc_number] => 04847079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-11 [patent_title] => 'Biologically stable interferon compositions comprising thimerosal' [patent_app_type] => 1 [patent_app_number] => 7/077957 [patent_app_country] => US [patent_app_date] => 1987-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1491 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/847/04847079.pdf [firstpage_image] =>[orig_patent_app_number] => 077957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2472982 [patent_doc_number] => 04871538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-10-03 [patent_title] => 'Insoluble copper-alpha interferon complex' [patent_app_type] => 1 [patent_app_number] => 7/072487 [patent_app_country] => US [patent_app_date] => 1987-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1007 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/871/04871538.pdf [firstpage_image] =>[orig_patent_app_number] => 072487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2629421 [patent_doc_number] => 04957734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-09-18 [patent_title] => 'Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis' [patent_app_type] => 1 [patent_app_number] => 7/070592 [patent_app_country] => US [patent_app_date] => 1987-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2931 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/957/04957734.pdf [firstpage_image] =>[orig_patent_app_number] => 070592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2557935 [patent_doc_number] => 04857315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-08-15 [patent_title] => 'Compositions containing golgi alpha-mannosidase II inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/065248 [patent_app_country] => US [patent_app_date] => 1987-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4686 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/857/04857315.pdf [firstpage_image] =>[orig_patent_app_number] => 065248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2585210 [patent_doc_number] => 04925831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-05-15 [patent_title] => 'Aminoalkyl naphthalenediols as host resistance enhancers against viral infection' [patent_app_type] => 1 [patent_app_number] => 7/060208 [patent_app_country] => US [patent_app_date] => 1987-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8862 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/925/04925831.pdf [firstpage_image] =>[orig_patent_app_number] => 060208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2595900 [patent_doc_number] => 04923852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-05-08 [patent_title] => 'Aminoalkyl naphthalenediols as host resistance enhancers against viral infections' [patent_app_type] => 1 [patent_app_number] => 7/060209 [patent_app_country] => US [patent_app_date] => 1987-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8864 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/923/04923852.pdf [firstpage_image] =>[orig_patent_app_number] => 060209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2644424 [patent_doc_number] => 04895716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Stabilized formulations of gamma interferons' [patent_app_type] => 1 [patent_app_number] => 7/059723 [patent_app_country] => US [patent_app_date] => 1987-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2434 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895716.pdf [firstpage_image] =>[orig_patent_app_number] => 059723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2628203 [patent_doc_number] => 04920209 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-24 [patent_title] => 'Oral vaccines' [patent_app_type] => 1 [patent_app_number] => 7/058002 [patent_app_country] => US [patent_app_date] => 1987-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5443 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/920/04920209.pdf [firstpage_image] =>[orig_patent_app_number] => 058002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2489494 [patent_doc_number] => 04801685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-01-31 [patent_title] => 'Microbial production of mature human leukocyte interferon K and L' [patent_app_type] => 1 [patent_app_number] => 7/056623 [patent_app_country] => US [patent_app_date] => 1987-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 14547 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/801/04801685.pdf [firstpage_image] =>[orig_patent_app_number] => 056623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2652896 [patent_doc_number] => 04929443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-05-29 [patent_title] => 'Method of treating interferon sensitive diseases, and a method and device for preparing .gamma.-interferon containing preparation' [patent_app_type] => 1 [patent_app_number] => 7/050470 [patent_app_country] => US [patent_app_date] => 1987-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/929/04929443.pdf [firstpage_image] =>[orig_patent_app_number] => 050470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2654795 [patent_doc_number] => 04961969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-09 [patent_title] => 'Process for recovering microbially produced interferon-.beta.' [patent_app_type] => 1 [patent_app_number] => 7/048686 [patent_app_country] => US [patent_app_date] => 1987-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8095 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/961/04961969.pdf [firstpage_image] =>[orig_patent_app_number] => 048686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2490210 [patent_doc_number] => 04847081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-11 [patent_title] => 'Synthetic bovine parainfluenza viral proteins' [patent_app_type] => 1 [patent_app_number] => 7/014499 [patent_app_country] => US [patent_app_date] => 1987-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8968 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/847/04847081.pdf [firstpage_image] =>[orig_patent_app_number] => 014499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2551648 [patent_doc_number] => 04806629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-02-21 [patent_title] => 'Monoclonal antibody to a human thymocyte antigen' [patent_app_type] => 1 [patent_app_number] => 7/030284 [patent_app_country] => US [patent_app_date] => 1987-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7300 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/806/04806629.pdf [firstpage_image] =>[orig_patent_app_number] => 030284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2598144 [patent_doc_number] => 04911908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-27 [patent_title] => 'Interferon administration vehicles' [patent_app_type] => 1 [patent_app_number] => 7/024833 [patent_app_country] => US [patent_app_date] => 1987-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8330 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/911/04911908.pdf [firstpage_image] =>[orig_patent_app_number] => 024833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2588259 [patent_doc_number] => 04917887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-17 [patent_title] => 'Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them' [patent_app_type] => 1 [patent_app_number] => 7/023634 [patent_app_country] => US [patent_app_date] => 1987-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12041 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/917/04917887.pdf [firstpage_image] =>[orig_patent_app_number] => 023634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2442798 [patent_doc_number] => 04721616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-01-26 [patent_title] => 'Treatment of vernal conjunctivitis' [patent_app_type] => 1 [patent_app_number] => 7/020048 [patent_app_country] => US [patent_app_date] => 1987-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 750 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/721/04721616.pdf [firstpage_image] =>[orig_patent_app_number] => 020048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2555246 [patent_doc_number] => 04853218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-08-01 [patent_title] => 'Zinc-protamine-alpha interferon complex' [patent_app_type] => 1 [patent_app_number] => 7/018243 [patent_app_country] => US [patent_app_date] => 1987-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1864 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/853/04853218.pdf [firstpage_image] =>[orig_patent_app_number] => 018243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2562699 [patent_doc_number] => 04849411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-07-18 [patent_title] => 'Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives' [patent_app_type] => 1 [patent_app_number] => 7/014618 [patent_app_country] => US [patent_app_date] => 1987-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 20618 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/849/04849411.pdf [firstpage_image] =>[orig_patent_app_number] => 014618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2588378 [patent_doc_number] => 04908432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-13 [patent_title] => 'Novel polypeptide having gamma-interferon activity' [patent_app_type] => 1 [patent_app_number] => 7/001786 [patent_app_country] => US [patent_app_date] => 1987-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7928 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/908/04908432.pdf [firstpage_image] =>[orig_patent_app_number] => 001786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2553520 [patent_doc_number] => 04897265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-30 [patent_title] => 'Method for treating disorders of the vascular and pulmonary systems' [patent_app_type] => 1 [patent_app_number] => 7/001848 [patent_app_country] => US [patent_app_date] => 1987-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 7291 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/897/04897265.pdf [firstpage_image] =>[orig_patent_app_number] => 001848 [rel_patent_id] =>[rel_patent_doc_number] =>)